“…SEVERE BLEEDING refractory to platelet transfusion can occur in ticagrelor-treated patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). 1,2 Postoperative bleeding risk is mitigated by holding ticagrelor for 3 days before surgery. 3 Ticagrelor undergoes hepatic metabolism via cytochrome (CYP) 3A4, forming active and inactive metabolites.…”